AzTrials
AzTrials

Pelvic ExamNCT03785548

Utilization of the Mirror During Pelvic Exams

An observational study of Pelvic Exam, run by TriHealth Inc. at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This is a prospective cohort study to determine if using a birthing mirror during the patient's pelvic examination decreases patients's degree of vulnerability and discomfort. Read more about this study

Who is it for?
Ages 18 to 80 years, women onlyHealthy volunteers can take part
Conditions the study is for
Pelvic Exam
What is being tested?
Usage of a mirror
How many people
147 participants
Where
1 siteUnited States
Study dates
15 Apr 2019to 1 Jul 2020
Phase
Observational
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: All women 18 years of age to 80, who undergo pelvic exam by a physician at Cincinnati Urogynecology Associates, TriHealth will be approached for recruitment.

Who may be able to join

  • New patients undergoing a pelvic exam performed by a physician at Cincinnati Urogynecology Associates, TriHealth

Who cannot join

  • Existing patients
  • Unwillingness to participate in the study
  • Physical or mental impairment that would affect the subject's ability to visualize the mirror during examination or to complete questionnaires
  • Inability to understand English

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Cincinnati Urogynecology Associates

    Cincinnati, Ohio, 45220

Other trials in United States

About this study

Official title: Utilization of the Mirror During Pelvic Exams: Does it Reduce Patient Vulnerability and Discomfort?

This is a prospective cohort study to determine if using a birthing mirror during the patient's pelvic examination decreases patients's degree of vulnerability and discomfort.

Read the detailed description

In Obstetrics and Gynecology and its gynecologic subspecialties, the pelvic examination is routine practice for screening and diagnostic purposes. Nevertheless, due to their intimate nature, pelvic examinations may result in loss of control, embarrassment, discomfort and anxiety.

The mirror pelvic exam has been a proposed technique to decrease patient anxiety and improve comfort during an already uncomfortable examination. However, little research has focused on this modality to date.

The purpose of this study is to investigate whether the mirror pelvic exam decreases the level of vulnerability and discomfort experienced during the pelvic examination.

Conditions
Pelvic Exam
Being tested
Usage of a mirror

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Usage of a mirrorOther

    using a mirror during the pelvic examination

Study groups in NCT03785548
Study groupRoleWhat they receive
Mirror groupThis group of patients agree to have the mirror pelvic exam, and they will undergo routine pelvic examination by a physician with the usage of a mirror in the room.
Receives: Other: Usage of a mirror
No mirror groupThis group of patients decline a mirror, and they will undergo the standard pelvic examination.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Group Difference in Visual Analog Scale (VAS) on Level of Vulnerability

    VAS on vulnerability level will be measured after the pelvic exam, and group difference after controlling for baseline vulnerability, will be calculated. The VAS is a validated 100 millimeter scale with 'no vulnerability' represented as 0 mm and 'very vulnerable' equating to 100 mm.

    Measured: 30 minutes after the pelvic exam

  2. Group Difference in Visual Analog Scale (VAS) on Level of Pain/Discomfort

    VAS on discomfort level will be measured after the pelvic exam, and group difference after controlling for baseline discomfort level, will be calculated. The VAS is a validated 100 millimeter scale with 'no pain' represented as 0 mm and 'most pain' equating to 100 mm.

    Measured: 30 minutes after the pelvic exam

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Dec 2018
  2. Study start15 Apr 2019
  3. Primary completion29 May 2020
  4. Study completion1 Jul 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
147 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03785548
Sponsor's protocol ID
18-107
Status last verified
Jul 2020
First submitted
19 Dec 2018
Last updated
17 Aug 2020
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Tam T, Crisp CC, Hill AM, Aldrich E, Ghodsi V, Yook E, Yeung J, Pauls RN. Utilization of a Mirror During Pelvic Examinations: Does it Improve the Patient's Experience? Female Pelvic Med Reconstr Surg. 2021 Mar 1;27(3):208-213. doi: 10.1097/SPV.0000000000000975.

    PubMed 33620906

Questions about this trial

What is this clinical trial studying?

An observational study of Pelvic Exam, run by TriHealth Inc. at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Aug 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 17 Aug 2020). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Group Difference in Visual Analog Scale (VAS) on Level of Vulnerability (time frame: 30 minutes after the pelvic exam). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03785548, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Aug 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in